References

Thyroid cancer

10.1016/s0140-6736(23)00020-x · 2023 · External reference

Current practice in patients with differentiated thyroid cancer

10.1038/s41574-020-00448-z · 2021 · External reference

Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution

10.1093/annonc/mdp050 · 2009 · External reference

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial

10.1016/s1470-2045(21)00332-6 · 2021 · External reference

Use of radioactive iodine for thyroid cancer

10.1001/jama.2011.1139 · 2011 · External reference

2022 ETA consensus statement: what are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

10.1530/etj-21-0046 · 2022 · External reference

2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer

10.1089/thy.2015.0020 · 2016 · External reference

False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer

2012 · External reference

The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics

10.1016/j.pharmthera.2012.06.007 · 2012 · External reference

Sodium iodide symporter: its role in nuclear medicine

2002 · External reference

A perspective view of sodium iodide symporter research and its clinical implications

10.1530/eje.1.02257 · 2006 · External reference

Clinical significance of hepatic visualization on iodine-131 whole-body scan in patients with thyroid carcinoma

1997 · External reference

Radioactive iodine therapy in differentiated thyroid cancer: an update on dose recommendations and risk of secondary primary malignancies

10.1053/j.semnuclmed.2024.05.002 · 2024 · External reference

Second primary malignancies in thyroid cancer patients

10.1038/sj.bjc.6601319 · 2003 · External reference

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy

10.1002/cncr.26070 · 2011 · External reference

Use of radioactive iodine for thyroid cancer and risk of second primary malignancy: a nationwide population-based study

10.1093/jnci/djv314 · 2016 · External reference

Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies

10.1200/jco.21.01841 · 2022 · External reference

Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer

10.1200/jco.2017.75.0232 · 2018 · External reference

Incidence of nonthyroidal primary malignancy and the association with (131)I treatment in patients with differentiated thyroid cancer

10.1089/thy.2016.0037 · 2016 · External reference

Data resource profile: the national health insurance research database (NHIRD)

10.4178/epih.e2018062 · 2018 · External reference

Taiwan's national health insurance research database: past and future

10.2147/clep.s196293 · 2019 · External reference

Risk factors and prognosis for metastatic follicular thyroid cancer

10.3389/fendo.2022.791826 · 2022 · External reference

Comorbidity burden and risk of second primary non-breast cancer in breast cancer survivors

10.1016/j.canep.2025.102867 · 2025 · External reference

Propensity score matching: a statistical method

10.1097/bsd.0000000000000932 · 2020 · External reference

Practical recommendations for reporting Fine–Gray model analyses for competing risk data

10.1002/sim.7501 · 2017 · External reference

A pan-cancer analysis of age and sex differences in cancer incidence and survival in the United States, 2001-2020

10.3390/cancers17030378 · 2025 · External reference

Cancer risk associated with chronic diseases and disease markers: prospective cohort study

10.1136/bmj.k134 · 2018 · External reference

Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer

10.1210/jc.2014-4332 · 2015 · External reference

Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition

10.1677/erc.1.01320 · 2006 · External reference

Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope

10.1002/jso.20656 · 2007 · External reference

Outcomes of patients with differentiated thyroid carcinoma following initial therapy

10.1089/thy.2006.16.1229 · 2006 · External reference

Chewing tobacco and radioiodine

10.1016/s0140-6736(67)91475-4 · 1967 · External reference

Sensitivity of salivary glands to radiation: from animal models to therapies

10.1177/0022034509343143 · 2009 · External reference

Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms

10.1089/thy.2012.0106 · 2013 · External reference

Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer

10.1118/1.3602459 · 2011 · External reference

Increased risk of salivary gland tumors after low-dose irradiation

10.1097/00005537-199807000-00026 · 1998 · External reference

Radiation and leukaemia: which leukaemias and what doses?

10.1016/j.blre.2022.101017 · 2023 · External reference

Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study

10.1016/s2352-3026(15)00094-0 · 2015 · External reference

Low-dose ionizing radiation exposure and risk of leukemia: results from 1950-1995 Chinese medical X-ray workers' cohort study and meta-analysis

10.1016/j.jncc.2022.01.001 · 2022 · External reference

Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer

10.1093/jnci/djad040 · 2023 · External reference

Physical activity in cancer prevention and survival: a systematic review

10.1249/mss.0000000000001937 · 2019 · External reference

Dietary restrictions and cancer prevention: state of the art

10.3390/nu17030503 · 2025 · External reference

Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France

10.1016/s2468-2667(24)00107-5 · 2024 · External reference

Cancer risk following smoking cessation in Korea

10.1001/jamanetworkopen.2023.54958 · 2024 · External reference

Second primary malignancies following thyroid cancer: a population-based study in Taiwan

10.1530/eje-13-0309 · 2013 · External reference

10.1007/978-3-031-18810-7

10.1007/978-3-031-18810-7 · 2023 · External reference

Radiation-induced tissue damage and response

10.1002/path.5389 · 2020 · External reference

Normal-tissue tolerance to radiopharmaceutical therapies, the knowns and the unknowns

10.2967/jnumed.121.262751 · 2021 · External reference

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project

10.1007/s00259-023-06295-0 · 2023 · External reference

Principles of radiological protection and application of ALARA, ALADA, and ALADAIP: a critical review

10.1590/1807-3107bor-2025.vol39.014 · 2025 · External reference

An introduction to propensity score methods for reducing the effects of confounding in observational studies

10.1080/00273171.2011.568786 · 2011 · External reference

Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

10.1093/annonc/mdz400 · 2019 · External reference

Multilevel factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer

10.1210/clinem/dgab139 · 2021 · External reference

Reflection on 30 years of Taiwanese national health insurance: analysis of Taiwanese health system progress, challenges, and opportunities

10.1016/j.jfma.2024.07.030 · 2024 · External reference

The characteristics of patients who quit smoking in the year following a cancer diagnosis

10.1007/s11764-021-01009-7 · 2022 · External reference

Cancer-related worry in Canadian thyroid cancer survivors

10.1210/jc.2014-3169 · 2015 · External reference

Survival and death causes in thyroid cancer in Taiwan: a nationwide case-control cohort study

10.3390/cancers13163955 · 2021 · External reference

Unresolved reference

External reference